OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options
Bernhard Maisch
Frontiers in Cardiovascular Medicine (2019) Vol. 6
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Carsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, et al.
Nature Reviews Cardiology (2020) Vol. 18, Iss. 3, pp. 169-193
Open Access | Times Cited: 831

COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, et al.
Journal of Molecular Histology (2020) Vol. 51, Iss. 6, pp. 613-628
Open Access | Times Cited: 420

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
Chen Chen, Yiwu Zhou, Dao Wen Wang
Herz (2020) Vol. 45, Iss. 3, pp. 230-232
Open Access | Times Cited: 409

Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment
Jeremy C. McMurray, Joseph W. May, Madeleine W. Cunningham, et al.
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 155

Myocarditis
Cristina Basso
New England Journal of Medicine (2022) Vol. 387, Iss. 16, pp. 1488-1500
Closed Access | Times Cited: 103

Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers
Giancarlo Trimarchi, Lucio Teresi, Roberto Licordari, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1051-1051
Open Access | Times Cited: 17

Viral Myocarditis—Incidence, Diagnosis and Management
Megan Olejniczak, Matthew C. Schwartz, Elizabeth M. Webber, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2020) Vol. 34, Iss. 6, pp. 1591-1601
Closed Access | Times Cited: 120

Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT
Jun‐ichi Kawada, Suguru Takeuchi, Hiroshi Imai, et al.
Journal of Cardiology (2020) Vol. 77, Iss. 2, pp. 174-178
Open Access | Times Cited: 106

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
Justin Coyle, Efehi Igbinomwanhia, Alejandro Sánchez-Nadales, et al.
JACC Case Reports (2020) Vol. 2, Iss. 9, pp. 1331-1336
Open Access | Times Cited: 87

Biomarkers for Myocarditis and Inflammatory Cardiomyopathy
Abhilash Suresh, Pieter Martens, W.H. Wilson Tang
Current Heart Failure Reports (2022) Vol. 19, Iss. 5, pp. 346-355
Open Access | Times Cited: 41

Biphasic dose response in the anti-inflammation experiment of PBM
Fang Nie, Shaolong Hao, Yu Ji, et al.
Lasers in Medical Science (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 26

Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice
Emil Brociek, Agata Tymińska, Andrea Silvio Giordani, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 874-874
Open Access | Times Cited: 23

Utilization of deceased donors during a pandemic: argument against using SARS-CoV-2–positive donors
Malay B. Shah, Raymond Lynch, Hanine El-Haddad, et al.
American Journal of Transplantation (2020) Vol. 20, Iss. 7, pp. 1795-1799
Open Access | Times Cited: 56

Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies
Emanuele Monda, Giuseppe Palmiero, Marta Rubino, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6462-6462
Open Access | Times Cited: 53

Update on myocarditis – what we know so far and where we may be heading
Andi Rroku, Jan Kottwitz, Bettina Heidecker
European Heart Journal Acute Cardiovascular Care (2020) Vol. 10, Iss. 4, pp. 455-467
Open Access | Times Cited: 49

Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis
Franziska Seidel, Manuel Holtgrewe, Nadya Al‐Wakeel‐Marquard, et al.
Circulation Genomic and Precision Medicine (2021) Vol. 14, Iss. 4
Open Access | Times Cited: 47

Immunopathogenesis and immunomodulatory therapy for myocarditis
Wu He, Ling Zhou, Ke Xu, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 9, pp. 2112-2137
Open Access | Times Cited: 17

Mitochondria Dysfunction at the Heart of Viral Myocarditis: Mechanistic Insights and Therapeutic Implications
Yasir Mohamud, Boaz Li, Amirhossein Bahreyni, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 351-351
Open Access | Times Cited: 16

Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases
Agata Mostkowska, Guy Rousseau, Noël J.‐M. Raynal
The FASEB Journal (2024) Vol. 38, Iss. 5
Open Access | Times Cited: 5

Diagnosis, Evaluation, and Treatment of Myocarditis in Children
Adam Putschoegl, Scott R. Auerbach
Pediatric Clinics of North America (2020) Vol. 67, Iss. 5, pp. 855-874
Closed Access | Times Cited: 42

Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro
Woan Ting Tay, Yi‐Hsien Fang, Suet Theng Beh, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2399-2399
Open Access | Times Cited: 40

Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
Ladislav Baťalík, Kateřina Filáková, Ivana Radkovcova, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 22

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens
Daniel Marrama, Jarjapu Mahita, Alessandro Sette, et al.
EBioMedicine (2022) Vol. 75, pp. 103807-103807
Open Access | Times Cited: 21

The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization
Kasper Favere, Manon Van Hecke, Sander Eens, et al.
Cardiovascular Pathology (2024) Vol. 72, pp. 107652-107652
Open Access | Times Cited: 4

Dysregulated CD4+ T Cells and microRNAs in Myocarditis
Jing Wang, Bo Han
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top